Cite
APA Citation
Norris, S., Ramael, S., Ikushima, I., Haazen, W., Harada, A., Moschetti, V., Imazu, S., Reilly, P. A., Lang, B., Stangier, J., & Glund, S. (2017). evaluation of the immunogenicity of the dabigatran reversal agent idarucizumab during Phase I studies. British journal of clinical pharmacology, 83, 1815–1825. http://access.bl.uk/ark:/81055/vdc_100047807172.0x000023